Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
McKesson
Express Scripts
Colorcon
McKinsey

Last Updated: August 19, 2022

Investigational Drug Information for Succinic acid


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the drug development status for Succinic acid?

Succinic acid is an investigational drug.

There have been 13 clinical trials for Succinic acid. The most recent clinical trial was a Phase 3 trial, which was initiated on October 8th 2020.

The most common disease conditions in clinical trials are Leukemia, Myelomonocytic, Juvenile, Autistic Disorder, and Preleukemia. The leading clinical trial sponsors are POLYSAN Scientific & Technological Pharmaceutical Company, Scientific Technological Pharmaceutical Firm Polysan, Ltd., and National Cancer Institute (NCI).

There are seventy US patents protecting this investigational drug and four international patents.

Recent Clinical Trials for Succinic acid
TitleSponsorPhase
Meglimine Sodium Succinate for Correction of Metabolic Acidosis in Critically Ill PatientsAtlant Clinical Ltd.Phase 2
Meglimine Sodium Succinate for Correction of Metabolic Acidosis in Critically Ill PatientsPOLYSAN Scientific & Technological Pharmaceutical CompanyPhase 2
International Trial of Efficacy of Cytoflavin in Head TraumaPOLYSAN Scientific & Technological Pharmaceutical CompanyPhase 3

See all Succinic acid clinical trials

Clinical Trial Summary for Succinic acid

Top disease conditions for Succinic acid
Top clinical trial sponsors for Succinic acid

See all Succinic acid clinical trials

US Patents for Succinic acid

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Succinic acid See Plans and Pricing Low residue soldering flux Delco Electronics Corporation (Kokomo, IN) See Plans and Pricing
Succinic acid See Plans and Pricing Cyclic hydrocarbons with an aminoalkyl sidechain The Upjohn Company (Kalamazoo, MI) See Plans and Pricing
Succinic acid See Plans and Pricing Composition for increasing the anti-cancer activity of an anti-cancer compound Otsuka Pharmaceutical Co., Ltd. (Tokyo, JP) See Plans and Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Succinic acid

Drugname Country Document Number Estimated Expiration Related US Patent
Succinic acid United Kingdom GB2243623 2010-05-04 See Plans and Pricing
Succinic acid United Kingdom GB2257988 2010-05-04 See Plans and Pricing
Succinic acid United Kingdom GB9106903 2010-05-04 See Plans and Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
McKesson
Express Scripts
Colorcon
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.